Kappa receptor mediated opioid dependence in rhesus monkeys

Debra E. Gmerek, James H. Woods

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


The kappa receptor-selective agonist U-50, 488 was administered chronically to rhesus monkeys. Tolerance developed to the overt behavioral effects of U-50, 488 without cross-tolerance to morphine. Withdrawal behaviors produced by deprivation, naloxone or quadazocine administration in U-50, 488-dependent monkeys consisted of hyperactivity, excessive grooming, and yawning. The syndrome was suppressed in a dose-related manner by a kappa agonist, ethylketazocine, but not by doses of morphine that suppressed its own withdrawal. The mu-selective antagonist, beta-funaltrexamine, at doses which are active in morphine-dependent monkeys, did not precipitate withdrawal in U50, 488-dependent monkeys. Dependence, which is the result of activity at the kappa receptor, was distinct from morphine dependence.

Original languageEnglish (US)
Pages (from-to)987-992
Number of pages6
JournalLife Sciences
Issue number11
StatePublished - Sep 15 1986
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Kappa receptor mediated opioid dependence in rhesus monkeys'. Together they form a unique fingerprint.

Cite this